← Back to headlines
hVIVO Acquires CRS Berlin to Expand Capabilities in Dermatology and Women’s Health Trials
Clinical research organization hVIVO has purchased Berlin-based firm CRS Berlin to bolster its specialized testing services for dermatological and female-focused medical studies. The acquisition strengthens hVIVO's geographic footprint and therapeutic expertise in Europe.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
